Journal article 50 views 14 downloads
Improving infant Neurocognitive Development and Growth Outcomes with micronutrients (INDiGO): A protocol for an efficacy trial in rural Gambia
Wellcome Open Research, Volume: 9, Start page: 377
Swansea University Authors: Daniel Tod, Greg Fegan
-
PDF | Version of Record
© 2024 Moore SE et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).
Download (749.16KB)
DOI (Published version): 10.12688/wellcomeopenres.21282.1
Abstract
Undernutrition during the early years of life has a harmful and irreversible impact on child growth and cognitive development. Many of the interventions tested to improve outcomes across infancy have had disappointing or inconsistent impact, a common feature being the absence of any attempt to provi...
Published in: | Wellcome Open Research |
---|---|
ISSN: | 2398-502X |
Published: |
F1000 Research Limited
2024
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa68101 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract: |
Undernutrition during the early years of life has a harmful and irreversible impact on child growth and cognitive development. Many of the interventions tested to improve outcomes across infancy have had disappointing or inconsistent impact, a common feature being the absence of any attempt to provide nutritional supplements to infants during the first six months. With increasing evidence of micronutrient deficiencies in this age group, alongside strong evidence that growth and developmental deficits begin before six months, a renewed focus on the micronutrient status of infants is required. This study is a five-arm, double-blind, placebo-controlled, randomised efficacy trial of micronutrient supplementation to mothers (during pregnancy or pregnancy and lactation) and infants (Day 8 to six months of age) in rural Gambia, where rates of micronutrient deficiencies are high. 600 pregnant women (<20 weeks gestation) will be enrolled into one of five trial arms and followed to 12 months post-partum. The primary outcome will be infant brain development at six months, with micronutrient status, growth and neurocognitive development to 12 months as secondary outcomes. This novel research will identify the most efficacious way of improving micronutrient status in infancy, and assess impact on infant developmental outcomes, providing an evidence base for future effectiveness trials and policy recommendations. ISRCTN registry ( ISRCTN15063705, 09/07/2021); Pan African Clinical Trials Registry ( PACTR202201552774601, 21/01/2022). [Abstract copyright: Copyright: © 2024 Moore SE et al.] |
---|---|
Item Description: |
Study protocol |
Keywords: |
Micronutrients, pregnancy, lactation, infancy, neurodevelopment, growth, intervention, Gambia |
College: |
Faculty of Medicine, Health and Life Sciences |
Funders: |
The INDiGO trial is funded by Wellcome, through a Senior Research Fellowship to the lead author (SEM; grant reference 220225). The trial will benefit from the infrastructure already in place at MRCG which is funded by the UK Medical Research Council (MRC) and the Department for International Development (DFID) under the MRC/DFID Concordat agreement.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
Start Page: |
377 |